Upload others
View 2
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Based on the 2015 NSTE-ACS Guidelines of the …...Based on the 2015 NSTE-ACS Guidelines of the European Society of Cardiology Test early. Treat right. Save lives. The first algorithm
Guidelines on NSTE-ACS (version 2015) - Task Force · Guidelines on NSTE-ACS (version 2015) - Task Force Expert Type of Relationship with Industry For ESC Guidelines: The report below
Guidelines NSTE ACS
2015 ESC Guidelines for the Management of NSTE-ACS
Dual Antiplatelet Therapy: Time for a Paradigm Shift? · 5 years after PLATO: ESC guidelines 2014 myocardial revascularization NSTE-ACS undergoing PCI STEMI undergoing PCI Windecker
ESC 2015 NSTE-ACS Guidelines · Presentation: In the morning (>6h ago) dyspnea + chest pain, 30min, no radiation, no sweating Never angina during exercise Asymptomatic at presentation
Quale, Quando e per Quanto DAPT in NSTE-ACS? - Full Daydocumenti.fullday.com/public/SIMEULAZIO15/slides/DELUCA_SIMEU LAZIO... · VII CONGRESSO REGIONALE SIMEU LAZIO OVERVIEW IN EMERGENCY
Redesigning the Acute Coronary Syndrome (NSTE- … business case FI… · Redesigning the Acute Coronary Syndrome (NSTE- ACS) pathway at Morriston Cardiac Centre - The case for change
Final Copy NSTE-ACS for Presentation
Anticoagulant Therapies, NSTE-ACS Guidelines, and Translation to Clinical Practice
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS
2007 ESC NSTE-ACS GUIDELINES
#442 NQF 0071: Persistence of Beta-Blocker Treatment After ... · In patients with concomitant NSTE-ACS [non-ST-elevation acute coronary syndrome], stabilized HF [heart failure],
CRUSADE: Contemporary Evaluation and Management of · PDF fileCRUSADE: Contemporary Evaluation and Management of 200,000 High-Risk NSTE-ACS Patients Page 2 AUGUST 2007 volUme 4 EmErgEncy
ACUTE CORONARY SYNDROME. Spectrum of ACS Characteristics of patients with NSTE-ACS at HIGH acute, thrombotic risk for rapid progression to MI or
Rule-outofnon ... · who require rapid invasive intervention, from low-risk patients with unstable angina pectoris [2]. For NSTE-ACS patients, time to the clinical decision is strongly
Acs ball etiquette class slides
ESC Guidelines: oral antiplatelet therapy before and in ... · 9 Recommendations for platelet inhibition in NSTE-ACS 2015 Recommendations Class Level Oral antiplatelet therapy A P2Y
Anticoagulation 2013 for NSTEMI and STEMI · zBivalirudin for STEMI, Fondaparinux for NSTE ACS, Coronary stents for ACS ... ≥12 h Sx non ST ↑ACS, mod–high risk
Guidelines on ACS-NSTE (TF21) - Task Force Members and ... · Agewall Stefan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator,
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI ) Dr Sajeer K T
Management of Acute Coronary Syndromes...Management of Non-ST Elevation Acute Coronary Syndromes (NSTE-ACS) April, 2017 Mark Schmidhofer p≤0.05 usually = NS • Nothing magic about
Anticoagulation Therapy in Percutaneous Coronary Interventionsstatic.livemedia.gr/kebe/documents/al17324_us63... · 2015. 9. 11. · Enoxaparin NSTE-ACS No differences in 30-day death/MI*
2014 Nste Acs Slide Set
2014 AHA/ACC Guideline for the Management of Patients …circ.ahajournals.org/content/circulationaha/early/2014/09/22/CIR... · Amsterdam EA, et al. 2014 AHA/ACC NSTE-ACS Executive
Operative Myokardrevaskularisation im akuten ... · 2014 ESC/EACTS Guidelines on myocardial revascularization Eur Heart J. 2014 5 NSTE-ACS: “Patients at very high risk (as defined
ADDRESSING THE COMPLIANCE GAP WHAT · ADDRESSING THE COMPLIANCE GAP Only one third of the eligible NSTE-ACS patients received timely PCI according to the guidelines1 Only 57.4% of
Chest Pain & Acute Coronary Syndromes (ACS) Clinical Pathway · Chest Pain & Acute Coronary Syndromes (ACS) Discharge Checklist STEMI and High -Risk NSTE-ACS Aspirin Yes No, bleeding
Stable CAD, NSTE-ACS, and STEMI: Three Challenging
NSTE ACS - cdn.ymaws.com€¦ · Risk Stratified by Timing Ischemic Guided (new term) Immediate Invasive < 2 hours Early Invasive < 24 hours Delayed Invasive 25‐72 hours 17 Formerly
![#442 NQF 0071: Persistence of Beta-Blocker Treatment After ... · In patients with concomitant NSTE-ACS [non-ST-elevation acute coronary syndrome], stabilized HF [heart failure],](https://img.pdfslide.us/doc/110x75/604263e58c2aca63cf6bb0df/442-nqf-0071-persistence-of-beta-blocker-treatment-after-in-patients-with.jpg)
![Rule-outofnon ... · who require rapid invasive intervention, from low-risk patients with unstable angina pectoris [2]. For NSTE-ACS patients, time to the clinical decision is strongly](https://img.pdfslide.us/doc/110x75/6120df9f8ab270101f41f405/rule-outofnon-who-require-rapid-invasive-intervention-from-low-risk-patients.jpg)
